Vertical: CFnBBase Year: 2017
Market Size (2017)
$3.63B
Projected (2028)
$9.40B
CAGR (2013–2028)
8.8%
Key Players
15+
The global gummy vitamins market has been largely benefiting from the several benefits that vitamins offer such as to maintain a regular balanced diet and increasing metabolism in a human body. Moreover, frequent incidences of vitamin deficiencies leading to issues such as bleeding gums, dandruffs, hair loss, and restlessness are influencing the minds of consumers to switch over to the intake of vitamin supplements. Moreover, the popularity of gummy vitamins is rising owing to growing consumer preference towards improved taste and easier-to-swallow vitamin supplements than regular multivitamin tablets. With several driving trends including the launch of organic gummy vitamins and in different flavors are expected boost the global market growth during the forecast period.
Wantstats analysts have predicted that gummy vitamins industry is about to grow at a steady pace. The global gummy vitamins market is poised to grow over USD 9.39 billion by 2028 at an estimated CAGR of 9.1% from 2018 to 2028. At the country level, Japan is anticipated to record the highest growth rate (9.93%) in the gummy vitamins market over the forecast period. Followed by France with a substantial growth rate (9.92%) during the assessment.
Among the type, multi-vitamins segment will dominate the global gummy vitamins market and is projected to reach USD 6.61 billion by 2028 at a CAGR of 9.20% in terms of value. Single vitamins segment is projected to grow at the substantial CAGR of 8.88% to reach USD 2.78 billion by 2028.
Global gummy vitamins market, by end user, adult segment dominated the gummy vitamins market and is projected to reach USD 6,618.5 million by 2028 and will register a healthy CAGR of 9.03% during the forecast period. Child segment is projected to reach USD 2,776.5 million by the end of 2028, registering the highest CAGR of 9.27% during the forecast period from 2018 to 2028.
Among the distribution channel, store-based segment will dominate the gummy vitamins market and is projected to reach USD 7,684.5 million by 2028 at a CAGR of 8.89% in terms of value. Non-store based segment is projected to grow at the substantial CAGR of 10.10% to reach USD 1,710.6 million by 2028.
The Gummy Vitamins Market market is projected to grow at a CAGR of 8.8% from 2013 to 2028.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansGummy vitamins are chewable supplements that come in several delectable flavors and pleasant texture appealing the consumers. These are sweet tooth gummies enriched with either single vitamin or multivitamin such as vitamin A, C, D, E, K, B-6, and B-12, among others. Gummy vitamins are usually preferred by consumers over vitamin pills or tablets are owing to the problem of pill fatigue faced by many consumers who are on medications. These gummy vitamins are available in different formulations separately for kids and adults. Moreover, they are available with different claims separately for men and women.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Process
Wantstats analysis is based on interviews with industry experts who offer insight into the market structure, market segmentation, technology assessment, competitive landscape (CL), market penetration, as well as the emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and the current market position. Furthermore, the varying trends in segments and categories in each region are studied and estimated based on primary and secondary research.
Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and industry performance. For this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next five to 10 years.
Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global gummy vitamins market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, and developments related to the market and technology. For this study, analysts have gathered information from various credible sources such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, and paid databases.
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the overall global gummy vitamins market. The key players in the market were identified through secondary research, and their market contributions in different applications across the globe were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Wantstats added before being presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for this study.
Base Year
2017
Historical Period
2013 – 2016
Forecast Period
2018 – 2028
Primary Interviews
150+
Historical data (2013–2017) and forecast period (2017–2028)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThreat of New Entrants
Gummy vitamins manufacturers are emphasizing the incorporation of major vitamins into more palatable and tasty candy forms. New players have to invest highly and face stringent regulations as gummy vitamins are treated as drug supplements. Moreover, the cost of these vitamins is also a major concern hindering the entry of new players, especially in developing regions. However, major pharma companies are expected to launch gummy vitamins in multiple flavors, apart from producing conventional vitamin supplements. These market players have the capital investment to position their products in a manner that would attract consumer attention and question their loyalty towards other brands. Moreover, the cost restraint is expected to lower in the coming years with improvements in technology and drug designing.
The threat of new entrants to the market is moderate.
Bargaining Power of Suppliers
There are numerous suppliers in the market, indicating that the manufacturers have the liberty to shift between raw material suppliers, which reduces their operational risks. Moreover, the suppliers are not only concentrated in one region but have a cross-regional presence, which minimizes the switching cost among manufacturers. However, cost-related factors in some underdeveloped and developing regions may hamper the distribution network as many suppliers would not risk business due to low supply-demand and non-availability of gummy vitamins manufacturers.
Therefore, the bargaining power of suppliers is moderate.
Threat of Substitutes
Gummy vitamins have conventional vitamin substitutes available in the form of vitamin tablets, syrups, and capsules.. Moreover, the gummy vitamins market is facing intense internal competition at product type and ingredient levels; as there are multiple gummy vitamin producing brands available across the globe.
The threat of substitutes in the gummy vitamins market is high.
Bargaining Power of Buyers
The market of gummy vitamins is fragmented as it has both new entrants and well-established pharmaceutical companies with their gummy vitamin brands. The presence of major industry players, such as Church & Dwight Co., and Nature’s Bounty, in the gummy vitamins market has created a loyal consumer base. However, there are numerous small scale and regional players. Hence, due to a large number of existing manufacturers in the market, the switching cost of consumer lowers. New entrants in the market are attracting consumers with their variety of offerings and comparatively lower costs. However, the consumers are skeptic to new entrants fearing ill-effects of vitamin overdose and incorporated vitamin authenticity into the product. Moreover, there is a high cost of switching from conventional vitamin supplements mainly because of the extensive R&D for gummy vitamin formulation and mixing.
The bargaining power of buyers is moderate in the global gummy vitamin market.
Rivalry
The rivalry in the gummy vitamins market is over the type and number of vitamins added into the gummies.. Moreover, the competitive rivalry among market players is over product positioning along with better palatability. The market players have started intensive marketing campaigns positioning the gummy vitamins at par with conventional vitamin supplements along with extensive range of flavors to choose from. However, in underdeveloped and developing regions fewer manufacturers are coming into the business due to high intial investment and low awareness of gummy vitamins among the population. in underdeveloped and developing regions have dampened the rivalry in these regions.
The intensity of competitive rivalry in the gummy vitamins market is moderate.
Market estimates by geography (2028)
InsightNorth America leads with $3.48B by 2028, while Europe is projected to grow fastest at a 9.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2013 | 2017 | 2028 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $557.05M | $1.07B | $2.02B | 9.0% | 22% |
| South America | $184.37M | $345.12M | $625.71M | 8.5% | 7% |
| Europe | $795.14M | $1.55B | $2.94B | 9.1% | 31% |
| North America | $981.09M | $1.87B | $3.48B | 8.8% | 37% |
| Middle East and Africa | $116.15M | $206.79M | $333.52M | 7.3% | 4% |
| Total | $2.63B | $5.05B | $9.40B | 8.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$9.40B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Multi-Vitamins | $6.61B | 8.9% | 70% |
| Single Vitamins | $2.78B | 8.6% | 30% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Gummy Vitamins Market covering market dynamics, competitive landscape, and strategic outlook.
The Gummy Vitamins Market market is projected to reach $9.40B by 2028, growing at 8.8% CAGR. The Multi-Vitamins segment holds the largest share.
The global gummy vitamins market is expected to witness substantial growth due to the increasing consumption of gummy vitamins among kids as well as adults. The sweet taste and availability of the nutritious product in several delectable flavors is mainly driving the growth of the market. Deficiency of various vitamins is the major concern among consumers in recent times which creates an opportunistic market for the players of gummy vitamins. However, certain side effects associated with the over-consumption of the product acts as a restraint for the growth of the market.
Gummy vitamins have come a long way from targeting kids and are currently available for all age groups. Prevalence of nutrient deficiencies, followed by pill fatigue, is primarily attracting adults toward chewable supplements, such as gummy vitamins. It is a known fact that processed junk food has held a prominent place in the American diet which has led to vitamin deficiency among the population. According to the US Department of Agriculture (USDA), 8 out of 10 Americans are deficient in vitamin E; 50 percent of Americans are deficient in vitamin A, vitamin C, and magnesium; and more than 50 percent of the general population is vitamin D deficient regardless of the age. Owing to this, there is an increased demand for vitamin supplements among adults. However, the desire to infuse the body with vitamins, coupled with a growing prescription load, has created pill fatigue among consumers for which the demand for gummy vitamins is expected to have substantial growth in the coming years. Moreover, pills and capsules taste unpleasant and are hard to swallow for which the adults are inclining toward chewable vitamins. Additionally, there are multivitamin gummies with a variety of pleasing flavors, such as berry, cherry, grape, peach, and orange, which attracts consumers to shift toward chewable supplements and is highly impacting the growth of the gummy vitamins market.
Gummy vitamins are mainly popular in the US and have gained popularity in some European countries recently. However, there is limited awareness and availability of gummy vitamins in developing countries such as China, India, Indonesia, Brazil, Argentina, and Malaysia. This provides a huge opportunity to the manufacturers of gummy vitamins to increase product penetration in untapped regions.
Moreover, the prevalence of vitamin deficiencies among the large population in developing countries is a major factor driving the growth of gummy vitamins in these regions. Additionally, a relaxed regulatory environment in these regions also acts as a driving factor for the market. For instance, a Chinese supplement manufacturer, Sirio Pharma stated on January 2019, “The industry expects to see a boom in China’s functional gummy market as the regulatory environment relaxes. This will assist the manufacturers to increase product penetration in the market.”
The growing awareness of gummy vitamins among the population in developing countries through social media marketing and product launches is expected to surge the growth of the market. Thus, the players are highly focusing on product launches catering to the population of an untapped market. For instance, in April 2018, the confectionery company Yupi launched its Youvit gummy vitamin in Indonesia and is looking forward to bringing it in other Asian markets. Additionally, the growth of organized retail sector in countries such as India and China will uphold the growth of gummy vitamins market.
Gummy vitamins are gaining high acceptance among all age groups and are observed to be a popular substitute for vitamin pills. They are widely available in a variety of shapes and flavors and provide the needed vitamins to the body. However, there are certain side effects associated with the over-consumption of gummy vitamins, which restricts the growth of the market. It is difficult to manufacture gummies with precision in vitamin content, hence discrepancies in the vitamin content can be a major concern. As the taste is similar to that of candy, consumers tend to consume a greater number of gummies at a time which leads to certain side effects harmful for the human body. Certain fat-soluble vitamins such as vitamin A, E, D, K, and minerals such as iron can build up to toxic levels quite easily. For instance, over-consumption of vitamin A can cause dizziness, nausea, headaches, skin irritation, and joint pain.
Moreover, most of the gummy vitamins are high in sugar content and contain artificial flavors, colors, and gelatin. Thus, the sticky texture of gummy vitamins tends to cling to tooth enamel, especially in the grooves of the teeth or in between the teeth, leading to dental decay. Thus, these properties of the product hamper the growth of the market.
The gummy vitamins have a pleasant taste as compared to vitamin pills as they are high in sugar content, which masks the unpleasant taste of nutrients. The high sugar content in gummy vitamins boosts the flavor, preserve the shelf life, and assist in achieving the desired texture. A single gummy might contain two grams or more of sugar, which is unhealthy when consumed in excess. It increases the calorie intake and is a major cause of obesity and chronic diseases, such as diabetes. The sugary gummy vitamin can also cause tooth decay. However, the manufacturers are working to overcome this challenge by including sugar alternatives such as honey, stevia, and maple syrup.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Gummy Vitamins Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
Company Headquarters: California, US Founded: 2013 Workforce: ~68 Company Working: Olly Public Benefit Corporation (OLLY, PBC) offers nutritional supplements in its product line. The company provides gummy multivitamins and wellness-boosting gummies for kids, women, and girls. The company also supplies healthy mocha mousse, chocolate chip prookies, vanilla pops, and smoothies, along with other products such as protein powders and protein bars.
Company Headquarters: Richmond, Canada Founded: 2009 Workforce: ~55 Company Working: Herbaland Naturals Inc. (Herbaland) is one of Canada’s leading producers of gummy supplements, manufacturing natural health products. The company manufactures gummy vitamin products for kids, adults, and vegans exporting its products to more than 30 countries across the world. It offers merchandise products and gummies through retailers and online website.
Company Headquarters: California, US Founded: 2018 Workforce: ~350 Company Working: Better Wellness Corp. (Bettera Wellness) manufactures health and wellness products, including gummy vitamins. Bettera Wellness is a market leader in producing confections with the help of various nutraceutical, functional, and botanical ingredients. The company offers its products through retailers and online stores with business operation spread across the US.
Company Headquarters: Barranquilla, Colombia Founded: 1977 Workforce: ~ 5,000 Company Working: Softigel by Procaps is a leading provider of contract development and manufacturing services in sophisticated softgel technologies for the worldwide pharmaceutical and nutraceutical industries. The company consists of eight manufacturing facilities in Latin America including its first FDA approved pharmaceutical plants in South America. In addition, the company’s products are sold and distributed in more than 50 countries across the globe. Besides this, the company deals with a range of soft gel technologies including softgels, unigel, chewgels, G-Tabs, versagel and other delivery systems. Apart from this, the company Funtrition division, by Procaps is a top provider of Contract Manufacturing services in sophisticated gummy technologies. Through its broad range of abilities and in-depth knowledge of gummy manufacturing and product development, its assist various businesses in bringing cutting-edge dietary supplement products to market more quickly while providing consumers with an exceptional experience, greater preference, and superior adherence to various therapies and health issues. In addition, the company has developed into an integrated CDMO that offers customers full-service, turnkey solutions for nutraceutical products across both development and delivery owing to its cutting-edge delivery platforms, which include gelatin and non-gelatin gummies made of agar and pectin as well as proven formulation, manufacturing, and regulatory expertise. The companies gummy manufacturing plant is certified by HACCP, GMP, organic, and Halal standards, as well as by Health Canada.
Company Headquarters: California, US Founded: 2000 Workforce: ~16 Company Working: Zanon Vitamec USA Inc. (Zanone Vitamec) offers a line of gummy vitamins under several brands. These gummy vitamins are pectin-based, with 100% natural flavors and are available in a variety of formulas, flavors, and shapes. The company distributes products across Asia-Pacific and North America.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
